Yahoo
NasdaqCM - Delayed Quote USD

RenovoRx, Inc. (RNXT)

1.3300 -0.1600 (-10.74%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for RNXT
  • Previous Close 1.4900
  • Open 1.4900
  • Bid 1.1500 x 200
  • Ask 1.2200 x 100
  • Day's Range 1.3400 - 1.4969
  • 52 Week Range 0.7010 - 2.5900
  • Volume 376,393
  • Avg. Volume 812,934
  • Market Cap (intraday) 60.022M
  • Beta (5Y Monthly) 0.97
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3100
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 7.12
  • Zacks Rating Neutral

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.

renovorx.com

17

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RNXT
58.33%
S&P 500 (^GSPC)
10.73%

1-Year Return

RNXT
31.03%
S&P 500 (^GSPC)
11.11%

3-Year Return

RNXT
33.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

RNXT
74.32%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 909k
Earnings -2.91M
Profit Margin -320.24%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-3M
-2M
-1M
0
-1200.0%
-1000.0%
-800.0%
-600.0%
-400.0%

Analyst Insights

View More

Analyst Price Targets

3.00
7.12 Average
1.3300 Current
14.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/28/2026
Analyst Ascendiant Capital
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 14 -> 14.5

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    60.25M

  • Enterprise Value

    51.16M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    26.81

  • Price/Book (mrq)

    6.71

  • Enterprise Value/Revenue

    25.89

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -64.90%

  • Return on Equity (ttm)

    -125.23%

  • Revenue (ttm)

    1.98M

  • Net Income Avi to Common (ttm)

    -12.29M

  • Diluted EPS (ttm)

    -0.3100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.48M

  • Total Debt/Equity (mrq)

    4.34%

  • Levered Free Cash Flow (ttm)

    -6.65M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.3300 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 03/11/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/09/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/06/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/05/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: